Peptron, Inc.

KOSDAQ 087010.KQ

Peptron, Inc. Total Assets for the year ending December 31, 2023: USD 40.32 M

Peptron, Inc. Total Assets is USD 40.32 M for the year ending December 31, 2023, a -25.25% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
  • Peptron, Inc. Total Assets for the year ending December 31, 2022 was USD 53.94 M, a -17.24% change year over year.
  • Peptron, Inc. Total Assets for the year ending December 31, 2021 was USD 65.18 M, a -39.68% change year over year.
  • Peptron, Inc. Total Assets for the year ending December 31, 2020 was USD 108.05 M, a 105.54% change year over year.
  • Peptron, Inc. Total Assets for the year ending December 31, 2019 was USD 52.57 M, a -18.05% change year over year.
Key data
Date Total Assets Current Liabilities Total Non-Current Liabilities Shareholders' Equity
Market news
KOSDAQ: 087010.KQ

Peptron, Inc.

CEO Mr. Ho-Il Choi
IPO Date July 22, 2015
Location South Korea
Headquarters 37-24, Yuseong-daero 1628 beon-gil
Employees 94
Sector Health Care
Industries
Pharmaceuticals Biotechnology
Description

Peptron, Inc. engages in the development of peptide-based medicines to treat chronic diseases. The company's technologies include long acting; and SmartDepot, an ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of drug. Its research and development products include Luphere Depot for prostate cancer, endometriosis, uterine fibroids, and puberty; SR-Octreotide (PT201) for the treatment of acromegaly; SR-Exenatide (PT302) to treat type 2 diabetes; and SR-Exenatide (PT320) for Parkinson's and Alzheimer's disease. Peptron, Inc. was founded in 1997 and is headquartered in Daejeon, South Korea.

StockViz Staff

January 15, 2025

Any question? Send us an email